Iptakalim, a novel ATP-sensitive potassium channel opener, inhibits pulmonary arterial smooth muscle cell proliferation by downregulation of PKC-α
Authors:
Open Access
- 1 November 2011
- journal article
- Published by Elsevier in Journal of Biomedical Research
- Vol. 25 (6) , 392-401
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Protein kinase Cα: disease regulator and therapeutic targetTrends in Pharmacological Sciences, 2010
- Potassium channel diversity in the pulmonary arteries and pulmonary veins: Implications for regulation of the pulmonary vasculature in health and during pulmonary hypertensionPharmacology & Therapeutics, 2007
- Hypoxia and hypoxia-inducible factor-1α promote growth factor-induced proliferation of human vascular smooth muscle cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Activation of PKCα and pulmonary vascular remodelling in broilersResearch in Veterinary Science, 2005
- Inhibition of hypoxia-induced proliferation and collagen synthesis by vasonatrin peptide in cultured rat pulmonary artery smooth muscle cellsLife Sciences, 2005
- Effects of iptakalim hydrochloride, a novel KATP channel opener, on pulmonary vascular remodeling in hypoxic ratsLife Sciences, 2004
- The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?Journal of Anatomy, 2002
- Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?Journal of Clinical Investigation, 2000
- Hypoxic pulmonary vasoconstrictionGeneral Pharmacology: The Vascular System, 1999
- Heterogeneity in the proliferative response of bovine pulmonary artery smooth muscle cells to mitogens and hypoxia: importance of protein kinase CCanadian Journal of Physiology and Pharmacology, 1997